Tech News
← Back to articles

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

read original related products more articles

The cash deal seeks to strengthen the French drugmaker’s immunization portfolio after it suffered setbacks in clinical trials.